Navigation Links
Morphotek Enters Into Agreements With Fox Chase Cancer Center to Acquire Clinical Samples for the Development and Validation of Companion Diagnostic Kits
Date:1/10/2012

herapy."

About MorphotekMorphotek®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology.  The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved output traits for commercial applications.  The company is currently focusing its platform on the development and manufacturing of therapeutic antibodies for the treatment of cancer, inflammation and infectious disease.  For more information, please visit www.morphotek.com.

About Fox Chase Cancer Center Fox Chase Cancer Center is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive years.  Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, visit Fox Chase's web site at www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427).

About Eisai Inc.Eisai Inc. was established in 1995 and began marketing its first product in the United State
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
2. Morphotek, Inc. Announces That Two Investigational Drugs Have Received Orphan Drug Designations
3. Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc.
4. MacuCLEAR, Inc. Raises More Than $1M in Financing and Enters into Strategic Pacific Rim Partnership
5. Medical Centers Worldwide Adopt Both Accurays CyberKnife and TomoTherapy Systems
6. Dehaier Medical Enters European Homecare Medical Product Market
7. Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging
8. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Megapharm Ltd. for Commercialization of Fanapt™ in Israel
9. HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters
10. CIVCO Enters CT Needle Guidance Market with RAD-GUIDE™ Launch
11. Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... International Corporation (NASDAQ: PRXL ) announced today that it ... May 18, 2015, in New York City.  Ingo Bank ... making a presentation on PAREXEL and discussing business developments at ... presentation will be available through the "Investors" section of PAREXEL,s ... of the main page, and a replay of the presentation ...
(Date:5/4/2015)... VALLEY, Calif. , May 4, 2015 ... biologic for psoriasis, today announced that preclinical and mechanism ... session at the Society of Investigative Dermatology (SID) Annual ... Atlanta, in Atlanta, Georgia . ... is advancing the development of RON2315, a novel, low ...
(Date:5/4/2015)... , May 4, 2015  By looking at ... to distinguish between two very different conditions that ... Theodore Henderson , MD, PhD., a ... cases, this study can help the ... therefore treatment options, for Post-Traumatic Stress Disorder (PTSD) ...
Breaking Medicine Technology:PAREXEL International to Present at UBS Healthcare Conference 2Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3
... Nov. 9, 2010 Argos Therapeutics ... and chief executive officer, will present on the potential of Argos, ... HIV at the APHA 138th Annual Meeting & Exposition in Denver, ... will take place at the Colorado Convention Center. Data ...
... ALR ), a global leader in enabling individuals ... merger of rapid diagnostics and health management, announced today that ... Conference being held November 16 - 17, 2010 at the ... attend.  Mr. Russell,s presentation is scheduled for Wednesday, November 17, ...
Cached Medicine Technology:Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition 2
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 ... insurance programs, announces the expansion of coverage for its ... a leading provider of industry-tailored insurance and proactive risk ... & Company, we are dedicated to providing our customers ... meet their many evolving needs. We are excited to ...
(Date:5/4/2015)... TROY Healthcare Solutions is proud to be a ... (RUG) Conference in Baltimore, MD from May 11 – ... provides an opportunity for clients to gather to network, ... In addition to sponsoring the event, TROY Healthcare Solutions ... Conference. Attendees can stop by the TROY booth and ...
(Date:5/4/2015)... May 04, 2015 Baptist Medical ... Stroke Association’s Get With The Guidelines®-Stroke Gold Plus ... Honor Roll. The award recognizes the hospital’s commitment ... the most appropriate treatment according to nationally recognized, ... , To receive the Gold Plus Quality Achievement ...
(Date:5/4/2015)... May 04, 2015 Now in its ... clinical leaders who have made outstanding contributions to the ... serve, both in acute and post-acute care settings. The ... Post-Acute Provider of the Year, Advanced Practice Clinician of ... Provider of the Year. Recipients are selected by IPC’s ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
Breaking Medicine News(10 mins):Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 2Health News:Insurance Leader McNeil & Company Expands Coverage for Emergency Services Insurance Program (ESIP), Launches Enhancements to Property and Casualty Insurance Package 3Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner North Atlantic Regional User Group Conference 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2
... , , WAYNE, Pa., July ... documentation software, workflow tools, consulting and staffing services has announced ... Marketing and Communications. Reporting directly to founder and CEO ... marketing initiatives that blend the strong brand of Precyse,s services ...
... , BATESVILLE, Ind., July 29 Hillenbrand, Inc. (NYSE: ... the market opens Wednesday, Aug. 12, 2009. The full text of ... site at www.HillenbrandInc.com . , , ... with investors and financial analysts the same day at 8 a.m. ...
... , CARLSBAD, Calif., July ... announced today that Cardiac Science Corporation has purchased a ... Group. Cardiac Science develops, manufactures, and markets ... and Holter systems, cardiac rehabilitation telemetry, and data management ...
... , , DARIEN, Conn., July 29 ... The Switch , a sparkling 100% juice, is expanding its availability ... Amazon.com, The Switch has added key retailers Tops, ... months. And the list of eager retailers keeps growing with Wegmans, ...
... , , CARMEL, Ind., ... announced that Christopher J. Foote has been promoted to vice president, ... in 1999 and served previously as senior managing actuary for asset-liability ... and shared actuarial services. , , ...
... , SAN DIEGO, July 29 ... solutions that can reach over 3.5 billion mobile phones globally, today announced ... industry leaders. , , Key Facts: , ... the 7-member advisory board is to provide Globaltel Media,s executive management team ...
Cached Medicine News:Health News:Precyse Solutions Taps Former Siemens Executive to Lead New Marketing Organization 2Health News:Hillenbrand Announces Third-Quarter Earnings Release Date and Conference Call 2Health News:Patriot Scientific Corporation Announces Cardiac Science Corporation's Purchase of a Moore Microprocessor Patent(TM) Portfolio License 2Health News:People Across the Country are Making The Switch! 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 3
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
True hemostasis management is achieved with the Hepcon HMS PLUS Hemostasis Management System from Medtronic. This multi-purpose, intuitive system easily performs in-vitro diagnostic procedures....
An Innovative New System to Help You Meet the Challenges of Anterior Spine Surgery...
Medicine Products: